Outlook Therapeutics, Inc.
OTLKNasdaqCIK 1649989HealthcareFiscal year ends Sep 30
Reports and events: 284 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3020:30 ET | 8-K | 3.01 Delisting notice | 0001104659-26-112356 |
| 2026-09-1820:30 ET | 8-K | 8.01 Other events | 0001104659-26-108952 |
| 2026-08-2720:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-102446 |
| 2026-08-1821:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-098415 |
| 2026-08-1423:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-26-000895 |
| 2026-08-1412:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-096510 |
| 2026-08-1412:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-096478 |
| 2026-08-1220:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-094848 |
| 2026-07-2421:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-086685 |
| 2026-07-2423:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-086406 |
| 2026-07-1620:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-084242 |
| 2026-06-2621:30 ET | 8-K | 3.01 Delisting notice | 0001104659-26-078337 |
| 2026-06-1612:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074346 |
| 2026-06-0101:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-26-000621 |
| 2026-06-0121:00 ET | DEF 14A | Proxy statementPeriod 2026-07-16 | 0001140361-26-023583 |
| 2026-06-0113:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-068659 |
| 2026-05-2920:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-068306 |
| 2026-05-2821:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-067614 |
| 2026-05-2611:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065992 |
| 2026-05-1823:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-062865 |
| 2026-05-1520:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-062632 |
| 2026-05-1320:36 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060305 |
| 2026-04-2320:30 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-047741 |
| 2026-04-2120:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-046014 |
| 2026-04-0720:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-040387 |
| 2026-03-2521:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-034601 |
| 2026-03-1613:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028103 |
| 2026-03-1121:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-026465 |
| 2026-03-1020:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-025893 |
| 2026-03-0522:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-024189 |
| 2026-02-1822:01 ET | 8-K | 3.01 Delisting notice | 0001104659-26-017118 |
| 2026-02-1722:01 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001104659-26-016554 |
| 2026-02-1713:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-015887 |
| 2026-02-1122:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-013470 |
| 2026-01-2622:01 ET | DEF 14A | Proxy statementPeriod 2026-03-10 | 0001140361-26-002406 |
| 2026-01-0212:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-000066 |
| 2025-12-1922:01 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001104659-25-123264 |
| 2025-12-1913:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-122786 |
| 2025-11-1321:15 ET | 8-K | 8.01 Other events | 0001104659-25-111316 |
| 2025-11-0322:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-105633 |
| 2025-09-2921:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094558 |
| 2025-09-0521:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-087886 |
| 2025-09-0221:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-086428 |
| 2025-08-1421:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011588 |
| 2025-08-1420:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-078622 |
| 2025-07-0120:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-064755 |
| 2025-06-0221:00 ET | 8-K | 8.01 Other events | 0001104659-25-055521 |
| 2025-05-2821:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000572 |
| 2025-05-2320:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052452 |
| 2025-05-1520:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-049411 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.